Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Combined With Taxane for HER-2-negative Metastatic Breast Cancer
NCT02865304Phase 3Unknown
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Dec 2016
- Primary completion
- Dec 2017
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of endostar in breast cancer, sponsored by Fujian Medical University Cancer Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02865304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865304.